Skip to main content

Citations Listing



Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol. 2021;7(2):230–237.



Wu C, Bannister W, Schumacker P, Rosen M, Ozminkowski R, and Rossof A; Economic Value of a Cancer Case Management Program; Journal of Oncology Practice 2014 10:3, 178-186.



Hersh, L et al. Health Literacy in Primary Care Practice. Am Fam Physician. 2015 Jul 15;92(2):118-24.



Smith, SG et al.  Social isolation, health literacy, and mortality risk: Findings from the English Longitudinal Study of Ageing. Health Psychol. 2018 Feb;37(2):160-169.



Mariotto A, Howlader N, Scoppa S, Green D; An Overview of Survival Statistics in SEER. 2001; 22.



Lifetime Risk of Developing or Dying from Cancer; American Cancer Society; 2021.



Yuan Ji et al.2016 May;18(3):438-445. doi: 10.1016/j.jmoldx.2016.01.003. Epub 2016 Mar 3. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.